Blending stakeholder perspectives including payer medical directors & contracting executives with hospital purchasing and IDN value analysis committees alongside innovative medical device manufacturers securing coverage and reimbursement for medical technologies throughout the spectrum of care in an uncertain and evolving environment.
In order to ensure robust market access and reimbursement of medical products and technologies, medical device industry executives must craft an intricate coverage plan which transcends multiple layers of stakeholders and decision makers, from the public and payer community, to coding administrators and hospital purchasing and value analysis committees. Striking a delicate balance which provides the appropriate type and level of evidence to support product value proposition throughout the healthcare supply chain is now an essential component of reimbursement and market access, and more important than ever before. Through discussions led by forward thinking stakeholders and industry executives, participants in the 14th Annual Medical Device Coverage & Reimbursement Conference will have an opportunity to not only hear from leaders in the field on the craft of medical device reimbursement, but also from stakeholders directly on how to best create a collaborative, productive engagement strategy which ensures product access.
Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | email@example.com